Using dissociation and enhancement time-resolved lanthanide fluorometry, we have developed a quantitative competitive (QC)-PCR for measuring parathyroid hormone-related protein (PTHrP) mRNA after reverse transcription. A cloned PTHrP cDNA target was also modified by deletion of 10 bp and insertion of 21 bp in the midregion of the fragment and cloned for use as a competitor (i.e., internal standard). Two primers spanning 362 bp of target and 373 bp of competitor were designed and one of the primers was biotinylated. Two oligonucleotide probes, one recognizing the target and the other hybridizing to the competitor, were labeled with Eu chelate. Two equal aliquots of PCR products were assayed with each probe separately in streptavidin-coated wells. After 35 PCR cycles, the competitor signal decreased exponentially (y ‫؍‬ e (3.74 ؊ 0.624x) ; r 2 ‫؍‬ 0.965) and the target signal increased exponentially (y ‫؍‬ e (1.14 ؉ 0.497x) ; r 2 ‫؍‬ 0.984) when 1000 copies/tube of the competitor and 0 -100 000 copies/tube of the target DNA were added. Log-transformed data for the ratio of target to competitor signals (y) and the copies of the target DNA added (x) were used for plotting the linear calibration curve (y ‫؍‬ 2.79؉2.76x; r 2 ‫؍‬ 0.976). This QC-PCR enables analysis of multiple samples simultaneously and can be used to study PTHrP gene expression in malignancy and physiology.
Because the polymerase chain reaction (PCR) provides extraordinary sensitivity in detection of rare copies of nucleic acid sequence, quantitative PCR methodology has been developed and used to study gene expression by mRNA quantification after reverse transcription (RT) 1 [1] [2] [3] [4] . To overcome tube-to-tube, sample-to-sample, and even day-to-day amplification variations during PCR [5, 6] , competitive PCR has been widely used, i.e., coamplification of a specific target DNA and known amounts of a competitor DNA [7] [8] [9] [10] [11] . The target and competitor DNAs share the same primer recognition sites and must be amplified with the same efficiency; their products are analyzed separately after PCR. Typically, quantification is performed by comparing the sample PCR signal of target DNA in a series of replicates with the coamplified PCR signal of various known amounts of competitor, referred to as the internal standard in this kind of assay [2] . When Wang et al. first described the method [1] , they used serial 1:3 dilutions of both sample and internal standard; quantification of one sample required running multiple PCR tubes simultaneously. Moreover, the two PCR products had to be physically separated before quantification.
In the present study, we have developed a quantitative competitive PCR (QC-PCR) to study expression of the parathyroid hormone-related protein (PTHrP) gene. The DNA solution hybridization assay makes use of Eu chelate-labeled oligonucleotide probes, which are measured by time-resolved fluorometry. The whole development process, demonstrated in Fig. 1 , enables analysis of multiple samples by means of one calibration curve covering a wide range (10 -100 000 copies).
competitor dna
Construction of the competitor is summarized in Fig. 2 . Two pairs of primers were designed, P-1/P-2 and P-3/P-4 ( Table 1 ). By use of the PTHrP cDNA as a template, two fragments of 185 bp (85-269) and 171 bp (450 -280) were amplified separately and purified by agarose gel electrophoresis. Both fragments had a terminal sequence of 17 nucleotides, at the downstream 5Ј-end of the first fragment and the upstream 5Ј-end of the second fragment. The end 13 nucleotides of the two sequences were complementary to each other. After purification, these two fragments plus PCR buffer, dNTP, and Taq DNA poly-merase were applied to a PCR run for 5 cycles of 2 min at 45°C and 2 min at 72°C to join the two fragments first, before the amplification primers P-1 and P-4 were added. After running for 35 cycles of 1 min at 94°C, 1 min at 60°C and 1 min at 72°C, the product was separated by agarose gel electrophoresis and the 377-bp band was excised. This fragment was cloned in a pCR TM II plasmid of 3932 bp by use of a TA Cloning kit (Invitrogen). This modified PTHrP cDNA fragment was used as a competitor, in which 10 bp of sequence (270 -279), which in- a. Based on the sequence of cDNA of PTHrP, two pairs of primers (P-1 and P-2; P-3 and P-4) were designed. b. After PCR, two DNA fragments were generated, F-1 and F-2. c. Because two terminal sequences (T-a and T-b) of F-1 and F-2 were complementary to each other, the two fragments could combine in the PCR. In addition, the hybridized sequences formed a 21-bp insert. d. The joined fragment amplified with P1/P4 was cloned in pCR II. The doubly underlined basepairs denote the restriction site of Sau 3AI. cluded the only Sau 3AI restriction site, was deleted and a 21-bp fragment was inserted. The modification has been confirmed by sequencing the competitor DNA with a Sequenase TM Version 2.0 DNA Sequencing kit (USB TM ; US Biochemical Corp.).
eu-chelate-labeled oligonucleotide probes
Two oligonucleotide probes were designed (Table 1) , one recognizing the target DNA (T-probe) and the other recognizing the competitor (C-probe). Custom oligonucleotide synthesis was performed by Genemed Biotechnologies with an Amino Linker C3 at the 5Ј-end. HPLC-purified oligonucleotides were dissolved in distilled water and vacuum-dried in aliquots of ϳ50 g. A Delfia Eu-Oligolabeling kit (Wallac Oy) was used for labeling. In brief, the labeling reagent, Eu-chelate of 4-[2-(4-isothiocyanatophenyl)ethyl]-2,6-bis[N,N-bis(carboxymethyl)aminomethyl]pyridine, was dissolved in distilled water and added to the dried oligonucleotide at a molar ratio of 60:1 for Eu-chelate:oligonucleotide. The labeling reaction solution was adjusted to pH 9.8 with 0.1 volume of 1 mol/L sodium carbonate in a final volume of 50 L (oligonucleotide ϳ1 g/L) and incubated for 20 h at room temperature. The Eu-labeled oligonucleotide probe was purified on a column of Sephadex G25 (Pharmacia). The pooled fractions containing the Eu-probe were concentrated by centrifugation in a Centricon -3 concentrator (Amicon) and aliquoted and frozen at Ϫ20°C. After characterization, the specific activity (per nanogram of Eu-oligo) of the T-probe was 13.4 ϫ 10 6 fluorescence counts/s; that of the C-probe was 9.6 ϫ 10 6 counts/s.
pcr and extraction of pcr products
PCR amplification was carried out with a programable thermal controller PTC-100 -96V (MJ Research, Watertown, MA) and a reaction volume of 25 L: 0.5 mol/L each for upstream and downstream primer ( The separately amplified products of target and competitor DNA were purified by gel electrophoresis in agarose of low-melting temperature (Boehringer Mannheim). The bands at 362 and 373 bp were excised and extracted by a Wizard TM PCR Purification kit (Promega). The two fragments were used for testing the detection limit and specificity of the T-probe and the C-probe, respectively.
solution hybridization assay
The hybridization assay was performed as illustrated in Fig. 3 . After PCR, two equal portions (10 L) of product were pipetted into streptavidin-coated microtitration strip wells (Wallac Oy); 90 L of Delfia assay buffer (per liter, 50 mmol of Tris-HCl, 0.15 mmol of NaCl, 0.5 g of NaN 3 , 5 g of bovine serum albumin, 10 mg of diethylenetriamine pentaacetic acid, and 0.1 mL of Tween 40) supplemented with 1 mol/L sodium chloride, was added to each well. After incubation with shaking for 1 h at room temperature, the wells were washed once with 300 L of Delfia washing buffer [25-fold dilution of NaCl 225 g/L, Tris-HCl 125 mmol/L, Germall II (Sutton Labs., Chatham, NJ) 25 g/L, and Tween-20 1.25 g/L, pH 7.2]; 100 L of denaturing solution (125 mmol/L NaOH, 125 mmol/L NaCl) was then added to each well and incubated with shaking for 5 min. After three washes, the PCR products were hybridized for 1 h at room temperature with Eulabeled probes diluted in the assay buffer, one portion with T-probe and another portion with C-probe (ϳ30 ng of Eu-T-probe and 40 ng of Eu-C-probe per well). After six stringent washes, 100 L of Delfia Enhancement Solution (Wallac Oy) was added. The plate was incubated with shaking for 30 min, and the fluorescence was measured by a Delfia 1234 plate fluorometer (Wallac Oy).
calculation
The target and competitor fluorescence signals in each PCR tube were used to calculate the target/competitor ratio (T/C ratio). All the T/C ratio values of the standard and samples and the number of molecular copies of the standard were log 10 -transformed. Linear regression analysis of the calibration curve (from 10 to 100 000 copies) was performed by using log T/C and log PTHrP cDNA copies in the standard. The PTHrP mRNA copies in the samples were calculated by use of the regression equation and calibrated in relation to copies per microgram of total RNA.
Results
When the same amounts of target and competitor DNA were coamplified in one tube for various numbers of PCR cycles, the fluorescence signal of the two products increased in parallel. The fluorescence signal of serial (2-fold to 16-fold) dilutions of a PCR product decreased proportionally and in parallel when detected with T-probe and C-probe. After immobilization of the PCR products from the target and competitor DNAs in separate streptavidincoated wells, 5 U of Sau 3AI restriction enzyme were added per well and incubated at 37°C for 1 h. Use of this restriction enzyme should cleave the PCR product of target DNA but not the product of competitor DNA because this unique restriction site was deleted during construction of the competitor DNA (see Fig. 2 , the doubly underlined sequence). The detected fluorescence signal for the target DNA product decreased to 8% of the control, whereas 88% of the signal from the competitor product remained. When the immobilized target and competitor DNA products were cross-detected, only the background signal was recorded.
The log ratio values of the two PCR products with 10 3 or 10 4 copies of competitor DNA and various amounts of target DNA were quite similar ( Fig. 4) , being between Ϫ1.0 and 1.0. In general, the values for 10 3 copies of the competitor were slightly higher than those for 10 4 copies, as compared with the same input target DNA. In addition, with 10 4 copies of competitor, the log ratio values corresponding to the low amount of target DNA were not adequately separated. Thus, we chose to use 10 3 copies of the competitor in the QC-PCR. Linear regression analysis of the log ratio of the two products and the log input copies of target DNA after 30 PCR cycles showed similar results when 10 3 copies of competitor were used, because the log ratio remained relatively constant, independent of the number of PCR cycles. We used 35 cycles in our study. Fig. 5 shows a representative calibration curve as well as the exponential alterations of the two PCR products for various amounts (0 -100 000 copies) of target DNA and a constant amount (10 3 copies) of added competitor DNA.
Based on four measurements of a sample cDNA (diluted 1:80) reverse-transcribed from total RNA of a lung cancer cell line (BEN cells, a positive control for PTHrP) that contained 26.7 (Ϯ 2.9) ϫ 10 6 copies of PTHrP mRNA per microgram of total RNA, the interassay CV was Ͻ11%. The intraassay CVs were 15%, 17%, 13%, and 10% for input of 50, 200, 2000, and 50 000 copies, respectively, of PTHrP cDNA (n ϭ 6). The respective recoveries from the input of 50, 200, 2000, and 50 000 copies of PTHrP cDNA were 58%, 62%, 80%, and 109% (n ϭ 6). 
Discussion
The quantitative competitive PCR described here provides a sensitive method for quantifying PTHrP mRNA in low abundance after RT. The present QC-PCR assay differs from others described previously by enabling accurate analysis of multiple samples with a single set of standards over a wide range instead of requiring multiple assays for the titration of each sample [1, 2] . The two PCR products of each tube do not need physical separation and can be measured simultaneously in different wells on the same plate by the respective Eu-probes. The assay can even tolerate imperfect amplification in the presence of partial inhibition because the ratio value of the two products remains only slightly affected. In addition to its low detection limit and high specificity, the assay also has a broad dynamic range (10 -100 000 copies in one PCR tube), takes a few hours instead of days, and uses no radioactive labeling. In addition, the Eu-labeled probe has a long bench-life (at least 1 year when kept at Ϫ20°C).
Theoretically, for competitive PCR, the target DNA yield (T) is given by T ϭ T 0 (1 ϩ E) n and the competitor DNA yield (C) is given by C ϭ C 0 (1ϩE) n , where T 0 and C 0 are the initial amounts, n is the number of PCR cycles, and E is the amplification efficiency. Because E and n are equal for both target and competitor in the same tube, the final product ratio (T/C) depends only on the initial amount of both species of DNA; i.e., T/C ϭ T 0 /C 0 . In the present QC-PCR, 1000 copies of the competitor DNA, the value at the middle of the logarithmic dynamic range, was added to a dilution series of target DNA for establishing a calibration curve. The ratio of final yield of target/ competitor should be equivalent to the ratio of the initial target/competitor concentrations, given Morrison and Gannon's demonstration that coamplification of different concentrations of different targets results in retention of the initial proportions [12] . All the PCR reactions were stopped in the plateau phase because the onset of this phase is simultaneous for all amplicons [12] and therefore quantification with competitor or internal standard DNA does not require exponential amplification [13, 14] .
In developing the present QC-PCR assay, we constructed the competitor DNA by means of a splice overlap extension PCR method. This resulted in the deletion of 10 bp and insertion of 21 bp at the midregion of the PTHrP cDNA fragment. By deleting some material, we could design a probe specific for detecting the wild-type PTHrP cDNA fragment; the insertion allowed us to design a probe specific for the competitor DNA; and both probes hybridized on the respective middle regions. In addition, the only restriction site for Sau 3AI was removed by the deletion and thus provided the possibility for checking the probe specificity. The two PCR products differ in size by 11 bp and can be distinguished by gel electrophoresis. In view of the inverse exponential relationship between DNA template size and amplification efficiency [15] , it is important to keep the difference of amplification size between target and competitor as small as possible.
Competitive PCR is not by itself a method for quantification; after amplification, the PCR products have to be accurately analyzed. For detection and analysis of amplified products, a large variety of methods are available [16] . We used a europium chelate to label both oligonucleotide probes. The dissociated Eu 3ϩ in acidic condition is rechelated by another chelator, which gives a strong fluorescence signal detectable by time-resolved fluorometry. The Eu-chelate has been used for labeling oligonucleotide probes in several studies, the probes in those studies having been introduced at the 5Ј-end of a 20-to 40-nucleotide-long tail of modified cytidines, which enabled the labeling of as many as 20 Eu-chelates per probe [17, 18] . In the present study, we used probes with one amino group at the 5Ј-ends for labeling. This single Eu-chelate-labeled probe is sensitive enough to detect the PCR product but results in low background.
A limitation of this QC-PCR is that the RT efficiency of the sample RNA was not controlled in the presence of an internal RNA standard. However, we extracted the total RNA from all the samples by standardized procedures, and carried out RT of 1 g of total RNA samples in parallel by use of the same RT master solution. This could keep the variations of RT in different samples as low as possible. In addition, the two primers for PCR were designed on the basis of sequences in two exons (exon 3 Top: Fluorescence signals of two PCR products with various known amounts of PTHrP cDNA (target DNA) coamplified with 1000 copies of competitor DNA after 35 PCR cycles (r 2 denotes the correlation coefficient of exponential regression). Bottom: The plotted calibration curve (r 2 denotes the correlation coefficient of linear regression). and exon 4 in the PTHrP gene) with an intron of 5500 bp in between. This should minimize problems from genomic DNA carryover contamination during RNA extraction.
In conclusion, this QC-PCR simplifies the analysis of multiple samples and should facilitate the studies of PTHrP gene expression in malignant and physiological states. In addition, the Eu-labeled oligonucleotide probe is safe and sensitive and has a long bench-life.
